Molina Healthcare director receives stock grant award

SOISTMAN FRANCIS S JR reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

SOISTMAN FRANCIS S JR reported acquisition or exercise transactions in this Form 4 filing.

Molina Healthcare director Francis S. Soistman Jr. received a grant of 237 shares of common stock on July 1, 2026. The shares were awarded under the company’s 2025 Equity Incentive Plan as part of his director compensation, based on the stock’s closing price of $232.55.

The filing notes that each director’s annual equity award is valued at $220,000, with $55,000 granted on the first day of each quarter. Following this grant, Soistman directly holds 907 shares of Molina Healthcare common stock.

Insider Trade Summary

Grant/Award: 237 shares

Grant/Award 1 txn

Insider SOISTMAN FRANCIS S JR

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	237	$232.55	$55K

Holdings After Transaction: Common Stock — 907 shares (Direct)

Footnotes (3)

1. F1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
2. F2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares.
3. F3. Represents the closing price of the Issuer's common stock on July 1, 2026.

Key Figures

Shares granted: 237 shares Grant price per share: $232.55 Quarterly equity award value: $55,000 +2 more

5 metrics

Shares granted 237 shares Common stock grant on July 1, 2026

Grant price per share $232.55 Closing price on July 1, 2026 used for award

Quarterly equity award value $55,000 One quarter of director’s annual equity award

Annual equity award per director $220,000 Aggregate dollar value of each director’s equity award

Shares held after grant 907 shares Total direct holdings following the transaction

Key Terms

Equity Incentive Plan, annual equity award, closing price

3 terms

Equity Incentive Plan financial

"Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director."

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

annual equity award financial

"The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted..."

closing price financial

"The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Molina Healthcare (MOH) director Francis Soistman report on this Form 4?

Director Francis S. Soistman Jr. reported receiving 237 shares of Molina Healthcare common stock. The shares were granted as part of his director compensation under the 2025 Equity Incentive Plan, based on the closing price on July 1, 2026.

Was the Molina Healthcare (MOH) Form 4 transaction an open-market stock purchase or a grant?

The transaction was a grant, not an open-market purchase. Soistman received 237 shares as a stock award under Molina Healthcare’s 2025 Equity Incentive Plan, in connection with his services as a director, at the July 1, 2026 closing price.

How is Molina Healthcare (MOH) compensating directors with equity according to this filing?

Each Molina Healthcare director receives an annual equity award valued at $220,000. One quarter of this amount, or $55,000, is granted on the first day of each quarter, using the stock’s closing price that day to determine the number of shares.

What stock price did Molina Healthcare (MOH) use to calculate the July 1, 2026 director grant?

Molina Healthcare used the $232.55 closing price of its common stock on July 1, 2026. This price determined that a $55,000 quarterly equity award translated into a grant of 237 shares for director Francis S. Soistman Jr.

How many Molina Healthcare (MOH) shares does director Francis Soistman hold after this grant?

After the July 1, 2026 stock grant, Francis S. Soistman Jr. directly holds 907 shares of Molina Healthcare common stock. This total reflects the addition of 237 shares awarded under the 2025 Equity Incentive Plan for his board service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 04:49 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SOISTMAN FRANCIS S JR

(Last) (First) (Middle)

200 OCEANGATE

SUITE 100

(Street)

LONG BEACH CALIFORNIA 90802

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A(1)		237(2)	A	$232.55(3)	907	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares.

3. Represents the closing price of the Issuer's common stock on July 1, 2026.

Remarks:

	Jeff D. Barlow, power of attorney for Francis Soistman	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)